C
Cytek Biosciences, Inc.
CTKB · NASDAQ · Healthcare · 606M
Closing price
$5.43
+1.31% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.0×
Enterprise value / EBITDAEV/EBITDA
-36.0×
Free cash flow yieldFCF yield
-1.3%
Return on equityROE
-19.5%
Operating margin
-20.0%
Net debt / EBITDAbalance-sheet strength
3.9×
Interest coverage
-85.2×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.